Exchange: NASDAQ·Updated 09:53 PM EDT
ABSI logo

ABSI Absci Corp

$8.84
$0.00
(0.00%)
Today
Closed $8.80
$0.04
(0.46%)
Overnight
Reported EarningsAug 11
Mkt Cap$1.51B
Vol2.75M

About ABSI

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
71

Bullish Sentiment

How do you feel about ABSI?

Advertisement|Remove ads.